Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 700.39 billion as of May 13, 2025. Its market cap has increased by 11.06% in one year.

Market Cap

700.39B

Enterprise Value

716.04B

Revenue

309.22B

Ranking

n/a

PE Ratio

20.16

Stock Price

1,223.80

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 700.39B, an increase of 7,193.23%. That is a compound annual growth rate of 20.62%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	700.39B	-9.64%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,045.76B
Divi's Laboratories	1,577.41B
Cipla	1,220.83B
Mankind Pharma	1,031.45B
Apollo Hospitals Enterprise	995.85B
Zydus Lifesciences	890.37B
Alkem Laboratories	600.28B
Fortis Healthcare	510.84B

Market Cap Rankings